|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41,500.00 VND | -0.48% |
|
-0.72% | -20.95% |
| 07-02 | Imexpharm Corporation Announces Cash Dividend for the Year 2025, Payable on July 21, 2026 | CI |
| 07-01 | Imexpharm Corporation Announces Management and Committee Changes, Effective June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.48% | -0.72% | -9.39% | -25.36% | -20.95% | -20.50% | +50.02% | +28.16% | +206.12% | 244M | |
| -0.19% | -0.19% | +5.85% | +26.85% | +12.75% | +53.97% | +167.38% | +415.62% | +1,431.02% | 1,084B | |
| -1.74% | -1.66% | +9.15% | +7.20% | +24.99% | +65.52% | +62.17% | +52.39% | +110.42% | 634B | |
| -1.47% | -4.85% | +10.20% | +16.95% | +8.72% | +30.32% | +84.71% | +113.08% | +286.03% | 447B | |
| +0.18% | -1.76% | +5.24% | +5.94% | +2.22% | +29.04% | +26.48% | -4.98% | +31.11% | 330B | |
| -6.22% | -8.14% | -2.04% | -12.58% | -3.16% | +28.87% | +31.18% | +54.42% | +193.11% | 295B | |
| -1.27% | -2.91% | +5.00% | +1.74% | +13.41% | +27.42% | +44.91% | +46.34% | +52.89% | 285B | |
| -0.93% | -3.57% | +18.79% | +34.46% | -1.57% | -27.74% | -39.70% | +17.57% | +71.80% | 218B | |
| -1.40% | -3.42% | +4.87% | +1.62% | +10.40% | +21.86% | +60.79% | +47.37% | +125.59% | 199B | |
| -0.94% | +2.31% | +7.02% | -5.48% | +9.42% | +18.60% | +77.44% | +96.87% | +55.72% | 169B | |
| +0.67% | -0.60% | -5.93% | -11.19% | -2.91% | -5.42% | -32.24% | -38.97% | -33.13% | 137B | |
| -1.22% | -7.07% | +10.08% | +9.83% | +8.24% | +2.45% | +42.45% | +147.63% | +444.62% | 127B | |
| +0.40% | -0.72% | +2.18% | -2.96% | +6.99% | +21.09% | -7.63% | -14.07% | -23.45% | 118B | |
| -1.01% | -2.22% | +2.94% | -9.58% | +7.40% | +37.51% | +48.83% | +9.23% | -5.71% | 105B | |
| +1.47% | +1.63% | -0.73% | -5.49% | -7.54% | -8.21% | -18.91% | -12.31% | +2.25% | 103B | |
| +0.19% | +1.07% | -1.42% | -17.16% | -10.72% | +6.62% | +88.35% | +74.59% | +499.92% | 74.31B | |
| +2.14% | -4.99% | +42.86% | +25.34% | +36.99% | +85.51% | +2.35% | -0.26% | -45.33% | 55.6B | |
| +2.96% | +3.40% | +21.05% | -3.20% | -6.65% | +4.14% | +14.92% | -9.39% | +269.59% | 52.46B | |
| -0.97% | +4.82% | +6.89% | -6.75% | +11.64% | +22.88% | +22.40% | +47.89% | +26.92% | 52.94B | |
| -0.91% | -0.06% | +7.36% | -1.15% | -3.90% | -1.91% | +15.67% | - | - | 42.83B | |
| Average | -0.60% | +2.08% | +7.00% | +1.45% | +4.79% | +19.60% | +37.08% | +56.38% | +194.71% | 226.39B | |
| Weighted average by Cap. | -1.05% | +2.37% | +6.74% | +9.77% | +9.57% | +33.72% | +70.34% | +136.11% | +441.56% |
- Stock Market
- Stocks
- IMP Stock
- Sector Imexpharm Corporation
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
